{
    "code": "13005391",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=13005391",
    "time": "2020-02-26 02:52:41",
    "許可證字號": "內衛藥輸字第005391號",
    "註銷狀態": "已註銷",
    "註銷日期": "74\/01\/28",
    "註銷理由": "自請註銷",
    "製造許可登錄編號": "",
    "有效日期": "95\/09\/06",
    "發證日期": "59\/07\/16",
    "許可證種類": "製　劑",
    "舊證字號": "17014449",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA01300539101",
    "中文品名": "１％延舒隆粉",
    "英文品名": "1% ENDURON POWDER",
    "適應症": "心臟性浮腫、腎性浮腫、肝性浮腫、藥劑所引起之浮腫（副腎皮質賀爾蒙ＡＣＴＨ）妊娠中毒所引起之浮腫、本態性高血壓、＊年性高血壓、惡性高血壓、腎性高血壓",
    "劑型": "140散劑",
    "包裝": "瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "METHYCLOTHIAZIDE",
    "限制項目": "02輸　入",
    "申請商名稱": "1403101100  臺灣大日本製藥股份有限公司",
    "申請商地址": "台北縣土城市土城工業區民生街５號",
    "主製造廠": [
        {
            "製造廠名稱": "FJP0043000  DAINIPPON PHARMACEUTICAL CO. LTD.",
            "製造廠廠址": "6-8,DOSHOMACHI 2-CHOME, CHUO-KU, OSAKA, JAPAN",
            "製造廠公司地址": "",
            "製造廠國別": "JAPAN",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "4028100800",
            "成分名稱": "METHYCLOTHIAZIDE",
            "含量描述": "10",
            "含量": "10.0000000000",
            "單位": "MG"
        }
    ]
}